Barry M. Salzman's most recent trade in Checkpoint Therapeutics Inc was a trade of 147,007 COMMON STOCK done . Disclosure was reported to the exchange on May 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Checkpoint Therapeutics Inc | Barry M. Salzman | Director | 28 May 2025 | 147,007 | 0 (0%) | 0% | - | COMMON STOCK | ||
| Checkpoint Therapeutics Inc | Barry M. Salzman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2025 | 12,195 | 147,007 (0%) | 0% | 0 | COMMON STOCK | |
| Checkpoint Therapeutics Inc | Barry M. Salzman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Dec 2024 | 17,638 | 134,812 (0%) | 0% | 0 | COMMON STOCK | |
| Checkpoint Therapeutics Inc | Barry M. Salzman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2024 | 50,000 | 117,174 (0%) | 0% | 0 | COMMON STOCK | |
| Checkpoint Therapeutics Inc | Barry M. Salzman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2024 | 32,051 | 67,174 (0%) | 0% | 0 | COMMON STOCK | |
| Checkpoint Therapeutics Inc | Barry M. Salzman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 17,483 | 35,123 (0%) | 0% | 0 | COMMON STOCK |